A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

NCT07254806 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Disc Disease

Interventions

BIOLOGICAL: IDCT (rebonuputemcel)
OTHER: Sham (No Treatment)

Sponsor

DiscGenics, Inc.